These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3725)

  • 1. Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies.
    Mukherjee C; Caron MG; Mullikin D; Lefkowitz RJ
    Mol Pharmacol; 1976 Jan; 12(1):16-31. PubMed ID: 3725
    [No Abstract]   [Full Text] [Related]  

  • 2. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G; Bottari S; Strosberg AD
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract]   [Full Text] [Related]  

  • 3. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.
    Zatz M; Kebabian JW; Romero JA; Lefkowitz RJ; Axelrod J
    J Pharmacol Exp Ther; 1976 Mar; 196(3):714-22. PubMed ID: 4608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):21-33. PubMed ID: 39243
    [No Abstract]   [Full Text] [Related]  

  • 6. Identity of [3H]dihydroalprenolol binding sites and beta-2 adrenergic receptors coupled with adenylate cyclase in guinea-pig skeletal muscle sarcolemma: general properties and structure-activity relationships.
    Wei JW; Sulakhe PV
    J Pharmacol Exp Ther; 1980 Jul; 214(1):186-96. PubMed ID: 6104715
    [No Abstract]   [Full Text] [Related]  

  • 7. Norepinephrine and BRL 37344 stimulate adenylate cyclase by different receptors in rat brown adipose tissue.
    Granneman JG
    J Pharmacol Exp Ther; 1990 Aug; 254(2):508-13. PubMed ID: 1974640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyliminoimidazolidines. Characterization of a class of potent agonists of octopamine-sensitive adenylate cyclase and their use in understanding the pharmacology of octopamine receptors.
    Nathanson JA
    Mol Pharmacol; 1985 Sep; 28(3):254-68. PubMed ID: 2993848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
    Chidiac P; Nouet S; Bouvier M
    Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor.
    Maguire ME; Van Arsdale PM; Gilman AG
    Mol Pharmacol; 1976 Mar; 12(2):335-9. PubMed ID: 4726
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of beta-adrenergic receptors by N-ethylmaleimide: permissive role of beta-adrenergic agents in relation to adenylate cyclase activation.
    Vauquelin G; Bottari S; Strosberg AD
    Mol Pharmacol; 1980 Mar; 17(2):163-71. PubMed ID: 6104781
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of beta adrenergic receptors in isolated frog erythrocyte plasma membranes.
    Mukherjee C; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):291-303. PubMed ID: 16207
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-adrenergic receptors in the brain, molecular mechanisms and regulation].
    Staneva-Stoĭcheva D; Bogoslovova T; Popov P
    Eksp Med Morfol; 1986; 25(3):1-6. PubMed ID: 2875865
    [No Abstract]   [Full Text] [Related]  

  • 17. Presence of both beta1- and beta2-adrenergic receptors in a single cell type.
    Homburger V; Lucas M; Rosenbaum E; Vassent G; Bockaert J
    Mol Pharmacol; 1981 Nov; 20(3):463-9. PubMed ID: 6120448
    [No Abstract]   [Full Text] [Related]  

  • 18. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
    Williams LT; Gore TB; Lefkowitz RJ
    J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization.
    Wessels MR; Mullikin D; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):10-20. PubMed ID: 39240
    [No Abstract]   [Full Text] [Related]  

  • 20. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.